New immunisation reference page: Eczema and immunisations

Eczema or atopic dermatitis is a common skin condition affecting people of any ages. Whilst it is recognised that vaccines can cause a flare of eczema symptoms, there is no causal relationship identified between eczema and immunisations in the literature. 

For further information on eczema and immunisation please refer to our MVEC page यहाँ

Questions and answers about COVID-19 vaccines

The Vaccine Education Center (VEC) at the Children's Hospital of Philadelphia (CHoP) has recently launched a new resource page answering common questions related to the development and safety of COVID-19 vaccines. Readers are also encouraged to submit their own questions directly to the VEC team for response.

To access this initiative please follow the link यहाँ

विकवैक्स (विक्टोरियन इम्यूनाइजेशन शेड्यूल) ऐप- वर्तमान में समीक्षा के दौर से गुजर रहा है

राष्ट्रीय टीकाकरण कार्यक्रम (एनआईपी) में 1 जुलाई 2020 से बदलाव हुए हैं। इसके परिणामस्वरूप, विकवैक्स, MVEC के विक्टोरियन टीकाकरण शेड्यूल एप्लिकेशन की वर्तमान में समीक्षा की जा रही है और इसे ऐप स्टोर और Google Play से हटा दिया गया है। यदि आपने विकवैक्स ऐप डाउनलोड किया है, तो कृपया इसे अपने उपकरणों से हटा दें क्योंकि यह वर्तमान टीकाकरण कार्यक्रम के साथ अद्यतित नहीं है। 

अंतरिम में, कृपया देखें विक्टोरियन टीकाकरण अनुसूची - जुलाई 2020

Coronavirus vaccine progress report: the projects bidding to win the race for a COVID-19 vaccine

With over 140 vaccine candidates in various stages of development globally, the ABC has taken a look at the role that Australian researchers are playing in the effort to produce a safe and effective vaccine for COVID-19. 

ABC: Coronavirus vaccine progress:the projects bidding to win the race for a COVID-19 vaccine 

To further explore the COVID-19 vaccine development process and hear from a variety of national and international experts, please subscribe to our podcast series:
COVID-19 Road to a vaccine 

New immunisation reference page: Vaccine development and safety

In an effort to promote confidence in the safety and efficacy of immunisation, MVEC has looked at the steps undertaken by vaccine candidates prior to being registered for use in vaccination programs. Post-licensure surveillance programs are also important for the early detection of any unexpected safety signals that may arise.

To learn more please visit our MVEC page Vaccine development and safety

New immunisation reference page: Live-attenuated vaccines in patients receiving regular red blood cell transfusions

Patients receiving regular red blood cell transfusions to treat chronic medical conditions such as transfusion dependent thalassaemia, sickle cell disease, inherited chronic haemolytic anaemias, or inherited bone marrow failure syndromes are often left unprotected from vaccine preventable diseases due to not meeting the required intervals between red blood cell transfusions. Evidence in this space is limited, however specialist advice suggests that immunisation of this patient group with live-attenuated vaccines is safe and recommended. As such, MVEC has created a new reference page outlining the process of immunisation for these patients. Please refer to एमवीईसी: नियमित लाल रक्त कोशिका संक्रमण प्राप्त करने वाले मरीजों में जीवित-क्षीण टीके अधिक जानकारी के लिए।



The International Coalition of Medicines Regulatory Authorities (ICMRA) statement about confidence in vaccine safety and effectiveness

In a global effort to promote confidence in the safety of vaccines, the International Coalition of Medicines Regulatory Authorities (ICMRA) have released new documentation explaining the scientific evaluation process undertaken by vaccine candidates prior to licensing, as well as discussing the ongoing safety surveillance that continues after they have been approved for use. These documents are targeted for both health care professionals as well as consumers.

Read more here:

ICMRA statement about confidence in vaccine safety and effectiveness (for healthcare professionals)

ICMRA statement about confidence in vaccines (for the general public)


Zostavax safety advisory

The Therapeutic Goods Administration (TGA) have reiterated their advice that Zostavax should not be administered to immunocompromised individuals as it is associated with a risk of mild-serious complications. This advice follows a report of a new case of a patient who was taking hydroxychloroquine and a low dose of prednisolone who died three weeks after receiving the Zostavax vaccine. Whilst it was found that the Zostavax was administered in line with existing recommendations it is important that health professionals are aware of the potential of this kind of very rare adverse event. 

Read more here:

TGA: Zostavax vaccine 

And for more information on Zoster and to access the Zostavax GP Decision Aid refer to the एमवीईसी: ज़ोस्टर immunisation reference page. 

COVID19 Road to a vaccine episode 7: Professor Norman Baylor

In episode 7 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford speaks with Professor Norman Baylor. Professor Baylor is the former Director of the Office of Vaccines Research and Review Center at the U.S. Food and Drug Administration (FDA) and is the President and CEO of Biologics Consulting and current advisor to the WHO.

In this episode they discuss:

  • The important role of regulatory authorities in the development and release of new vaccines
  • Emergency Use Authorisations (EUA) and their use
  • Compressed timelines in the development of SARS-CoV-2 vaccines
  • Requirements of regulatory bodies in the development of vaccines
  • Opportunities for collaboration/”work-sharing” between the national regulatory bodies (FDA, EMA and TGA)
  • The role of regulatory bodies in vaccine safety


Download the episode at:

स्प्रेकर - सेब - Spotify 

राष्ट्रीय टीकाकरण कैच-अप कैलकुलेटर v1.0 अब उपलब्ध है

ऑस्ट्रेलियाई सरकार के स्वास्थ्य विभाग ने राष्ट्रीय टीकाकरण कैच-अप कैलकुलेटर (एनआईसीसी) का पहला संस्करण जारी किया है। यह ऑस्ट्रेलियाई टीकाकरण हैंडबुक वेबसाइट पर उपलब्ध है और दक्षिण ऑस्ट्रेलियाई स्वास्थ्य विभाग द्वारा होस्ट किए गए टीकाकरण कैलकुलेटर की जगह लेता है। 

आप यहां एनआईसीसी तक पहुंच सकते हैं:

राष्ट्रीय टीकाकरण कैच-अप कैलकुलेटर